Search Results 61-70 of 17945 for Lupus

  1. Anifrolumab-fnia (intravenous route) - Side effects & uses - Mayo Clinic

    Anifrolumab-fnia injection is used to treat moderate to severe systemic lupus erythematosus (SLE) in patients who are also receiving other lupus treatments.

  2. Observational Multicenter Case-control Study to Assess Nailfold Capillary Abnormalities in Systemic Lupus Erythematosus - Mayo Clinic

    The purpose of this study is to investigate the role of nailfold capillaroscopy in the assessment of patients with Systemic Lupus Erythematosus (SLE).

  3. Sjogren's syndrome - Symptoms and causes - Mayo Clinic

    The condition often accompanies other immune system disorders, such as rheumatoid arthritis and lupus. In Sjogren's syndrome, the mucous membranes and ...

  4. A Study of the Safety and Tolerability of JNJ-55920839, Either as a Single Ascending Dose in Healthy Individuals or as Multiple Doses for Patients who have Mild to Moderate Systemic Lupus Erythematosus - Mayo Clinic

    ... Lupus International Collaborating Clinics (SLICC) criteria for diagnosis of lupus ... Has active Central nervous system (CNS) lupus or history of severe CNS lupus ...

  5. MONDAY HOUSECALL: Stress and Blood Pressure, Emotional Eating, Lupus and more ...

    MONDAY HOUSECALL: Stress and Blood Pressure, Emotional Eating, Lupus and more … ... Lupus: Can it cause hair loss? Fiber supplements: Safe to take every day ...

  6. Medical Research & Education - Mayo Clinic News Network

    Science Saturday: Lupus rates increasing, communities of color especially vulnerable featured image. Science Saturday. Science Saturday: Lupus rates ...

  7. Medical Research & Education - Mayo Clinic News Network

    Science Saturday: Lupus rates increasing, communities of color especially vulnerable featured image. Science Saturday. Science Saturday: Lupus rates ...

  8. Medical Research & Education - Mayo Clinic News Network

    Science Saturday: Lupus rates increasing, communities of color especially vulnerable featured image. Science Saturday. Science Saturday: Lupus rates ...

  9. A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Active Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) - Mayo Clinic

    Diagnosis of discoid/subacute cutaneous lupus erythematosus (DLE/SCLE) for at least 3 months prior to screening visit. · Meets both clinical and ...

  10. A Study to Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms - Mayo Clinic

    ... lupus erythematosus (CLE) or systemic lupus erythematosus (SLE) showing some skin symptoms. Participation eligibility. Participant eligibility includes age ...